Rothschild Investment »

Actuate Therapeutics shares owned by Rothschild Investment

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2026-03-31 $35 13 2.77

More positions owned by Rothschild Investment

Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Invesco Rafi Us 1000 Etf Etf (PRF)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Amazon Stock (AMZN)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Exxon Mobil Corp Stock (XOM)
Johnson & Johnson Stock (JNJ)
Capital Group Dividend Growers Etf Etf (CGDG)
Blackstone Stock (BX)
Abbvie Stock (ABBV)
Chevron Corporation Stock (CVX)

View all positions for Rothschild Investment

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Group
BlackRock
Vanguard Capital Management
Geode Capital Management
Connective Capital Management
Northern Trust
Texas Capital Bank Wealth Management Services
Vanguard Fiduciary Trust
State Street Corporation
Vanguard Portfolio Management
ABS Direct Equity Fund
Rock Creek Group
Deutsche Bank Aktiengesellschaft

View all funds holding Actuate Therapeutics